United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

octapharma ltd - simoctocog alfa - powder and solvent for solution for injection - 2000unit

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

octapharma ltd - simoctocog alfa - powder and solvent for solution for injection - 500unit

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

octapharma pharmazeutika produktionsges. m.b.h. - human blood coagulation factor ii, human blood coagulation factor vii, human blood coagulation factor ix, human blood coagulation factor x, protein c, protein s - powder and solvent for solution for infusion - 14-38iu/ml+ 9-24iu/ml+ 25iu/ml+ 18-30iu/ml+ 13-31iu/ml+ 12-32iu/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

octapharma limited - human albumin - solution for injection - 20 %w/v

Ireland - English - HPRA (Health Products Regulatory Authority)

octapharma limited - human albumin - 20 millilitre

Ireland - English - HPRA (Health Products Regulatory Authority)

octapharma limited - anti-d immunoglobulin - pdr+solv for soln for inj - 1250 iu international unit

Australia - English - Department of Health (Therapeutic Goods Administration)

octapharma australia pty ltd - immunoglobulin - normal -

Australia - English - Department of Health (Therapeutic Goods Administration)

octapharma australia pty ltd - immunoglobulin g - human; human normal immunoglobulin -

Australia - English - Department of Health (Therapeutic Goods Administration)

octapharma australia pty ltd - 33963 - intravenous start kit - a packaged collection of equipment that includes needles and tubing that is used to establish intravenous (iv) access for the administration of intravenous solutions.

New Zealand - English - Medsafe (Medicines Safety Authority)

octapharma new zealand ltd - anti-d [rho] immunoglobulin 625 iu/ml; plasma protein fraction 165 mg/ml (human) - solution for injection - 1250 iu - active: anti-d [rho] immunoglobulin 625 iu/ml plasma protein fraction 165 mg/ml (human) excipient: glycine immunoglobulin a. not less than or equal to.05% of total protein polysorbate 80 sodium tributyl phosphate water for injection - · prevention of rh(d) immunisation in rh(d) negative women. - pregnancy/delivery of a rh-positive baby. - abortion/threatened abortion, ectopic pregnancy or hydatidiform mole. - transplacental haemorrhage (tph) resulting from ante-partum haemorrhage (aph), amniocentesis, chorionic biopsy or obstetric manipulative procedures, e.g. external version, or abdominal trauma. · treatment of rh(d) negative persons after incompatible transfusions of rh(d) positive blood or other products containing red blood cells.